Sung Young-sook, chairwoman of Hanmi Pharmaceutical Group, said in her New Year's message posted on the company intranet on ...
Snake zodiac leaders drive pharma and bio growth in South Koreas 2025 economy Zodiac leaders fuel pharmaceutical and ...
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
Multiple Sclerosis companies are Immune Response BioPharma, Clene Nanomedicine, Genzyme, ImStem Biotechnology, Rho, Inc., ...
Hosted on MSN22d
Bid to oust Hanmi Pharmaceutical leadership failsHanmi Pharmaceutical CEO Park Jae-hyun at the extraordinary shareholder meeting held in Songpa District, southern Seoul, on Thursday. [YONHAP] Efforts to seize the management rights of Hanmi ...
THE CHOSUNILBO on MSN14d
“Alliance of Four” gains control amid Hanmi family’s year-long power struggleA year-long management dispute within the Hanmi Pharmaceutical Group family is nearing resolution. The conflict began in ...
Merck & Co. Inc. has turned to Asia for a second time to get into the GLP-1 market, this time to Shanghai-based Hansoh Pharmaceutical Group Co. Ltd. for its investigational preclinical oral ...
Encequidar mesylate + paclitaxel is under clinical development by Hanmi Pharmaceuticals and currently in Phase II for Breast Cancer. According to GlobalData, Phase II drugs for Breast Cancer have a 30 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback